 |
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
|
Issue: May 2025
Volume 10 | Issue 5
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.14
Issue per Year : 12
Volume Published : 10
Issue Published : 108
Article Submitted : 15207
Article Published : 6791
Total Authors : 18222
Total Reviewer : 664
Total Countries : 121
Indexing Partner
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | A Validated Rp-Hplc Method for Tablets Containing Amlodipine Besylate and Telmisartan Hcl as Active Pharmaceutical Ingredient. |
| Authors Name: | Shaila Sumaiya , Anjali Bharadwaj |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJRTI_181341
|
| Published Paper Id: | IJRTI2009002 |
| Published In: | Volume 5 Issue 9, September-2020 |
| DOI: | |
| Abstract: | The LC method for the determination of test procedures of Assay for Amlodipine Besylate and Telmisartan HCl in bulk drug, and tablets were simple, reliable, sensitive and less time consuming. The positivity of the present working procedures was a simple isocratic method. The present method can be used for rapid and precise quantification of Amlodipine Besylate and Telmisartan HCl. The present work showing a validation with highly sensitive and selective method for the estimation of Amlodipine Besylate and Telmisartan HCl in pharmaceutical dosage forms. |
| Keywords: | HPLC, Amlodipine Besylate, Telmisartan HCl , Chromatogram , Validation . |
| Cite Article: | "A Validated Rp-Hplc Method for Tablets Containing Amlodipine Besylate and Telmisartan Hcl as Active Pharmaceutical Ingredient.", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.5, Issue 9, page no.7 - 22, September-2020, Available :http://www.ijrti.org/papers/IJRTI2009002.pdf |
| Downloads: | 000204825 |
| ISSN: |
2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID: IJRTI2009002
Registration ID:181341
Published In: Volume 5 Issue 9, September-2020
DOI (Digital Object Identifier):
Page No: 7 - 22 Country: HYDERABAD, TELANGANA, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2009002 Published Paper PDF: https://www.ijrti.org/papers/IJRTI2009002 |
| Share Article: | |
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijrti.org
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | DOAJ : Directory of Open Access Journals |
| DRJI | Index Copernicus International | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED,
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
| Providing A digital object identifier by DOI.ONE How to Get DOI? |
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Join RMS/Earn 300
WhatsApp
Click Here
Click Here
Indexing Partner |
|||
| Copyright © 2025 - All Rights Reserved - IJRTI | |||